ŽOURKOVÁ, Alexandra, Eva HADAŠOVÁ, Lucie PULKRÁBKOVÁ, Barbora RAVČUKOVÁ and Tomáš KAŠPÁREK. Clinical impact of CYP2D6 activity in long-term paroxetine treatment. In New developments in anxiety disorder research. New York: Nova Science Publishers, 2006, p. 177-198, 21 pp. 1 edition (2006/6/14). ISBN 1-59454-778-5. |
Other formats:
BibTeX
LaTeX
RIS
@inbook{702291, author = {Žourková, Alexandra and Hadašová, Eva and Pulkrábková, Lucie and Ravčuková, Barbora and Kašpárek, Tomáš}, address = {New York}, booktitle = {New developments in anxiety disorder research}, keywords = {anxiety disorder - paroxetine - side effects - CYP2D6 - phenotype - genotype}, language = {eng}, location = {New York}, isbn = {1-59454-778-5}, pages = {177-198}, publisher = {Nova Science Publishers}, title = {Clinical impact of CYP2D6 activity in long-term paroxetine treatment}, year = {2006} }
TY - CHAP ID - 702291 AU - Žourková, Alexandra - Hadašová, Eva - Pulkrábková, Lucie - Ravčuková, Barbora - Kašpárek, Tomáš PY - 2006 TI - Clinical impact of CYP2D6 activity in long-term paroxetine treatment VL - 1 edition (2006/6/14) PB - Nova Science Publishers CY - New York SN - 1594547785 KW - anxiety disorder - paroxetine - side effects - CYP2D6 - phenotype - genotype N2 - The aim of study was comparison of distribution of therapeutic efficaccy and side effects of long-term paroxetine treatment according to metabolic status. Statistically significant difference was only in poor metabolisers CYP2D6 in severity of sexual dysfunction. ER -
ŽOURKOVÁ, Alexandra, Eva HADAŠOVÁ, Lucie PULKRÁBKOVÁ, Barbora RAVČUKOVÁ and Tomáš KAŠPÁREK. Clinical impact of CYP2D6 activity in long-term paroxetine treatment. In \textit{New developments in anxiety disorder research}. New York: Nova Science Publishers, 2006, p.~177-198, 21 pp. 1 edition (2006/6/14). ISBN~1-59454-778-5.
|